Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation. Kang W, Shen CY, Cheng MC, Yan VKC, et al. Thromb Haemost 2026 Jan 30. doi: 10.1055/a-2785-8686.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang W, Shen CY, Cheng MC, Yan VKC, et al. Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation. Thromb Haemost 2026 Jan 30. doi: 10.1055/a-2785-8686.
PMID: 41617148